XLV vs JDOC
YTDYear to date
XLV wins+6.9 pts
Past year
XLV wins+7.6 pts
Fee
XLV winslower fee
Yield
XLV wins+0.6 pts
AUM
XLV5029.0× more
4–0XLV wins
XLV and JDOC · year-to-date · as of Nov 6, 2026 · AUM not scored
JDOC vs S&P 500
3M$65.97 · −2.4% last sessionDividend-adjusted total return. S&P 500 uses VOO.CompareS&P 500+ Peer avg+ Add a fund
Return1D1M3M ▼YTD1Y3Y5YMAX
Total return−2.4%+9.6%+6.8%+14.0%+22.0%——+44.1%
Peer average−3.4%+4.6%+3.5%+19.7%+29.0%+75.3%+27.3%—
S&P 500 · VOO−4.4%−5.7%−4.9%+8.4%+9.8%+82.2%+71.6%+790.6%
J.P. Morgan JDOC and Vanguard VOO · total return, dividends in · as of Nov 6, 2026
JDOC’s Holdings
TodayLLYEli Lilly And Company8.6%ABBV8.3%UNH5.3%NOVN.SW4.6%JNJ4.6%TMO4.3%AZN.L4.2%MRK3.6%DHR2.8%ISRG2.8%SYK2.3%BMY2.1%COR2.1%IQV2.0%REGN2.0%4502.T1.9%ROP.SW1.8%HUM1.8%EW1.8%BIIBBAYN.VRTX32 more
LLYEli Lilly And Company8.6%ABBV8.3%UNH5.3%NOVN.SW4.6%JNJ4.6%TMO4.3%AZN.L4.2%MRK3.6%DHR2.8%ISRG2.8%SYK2.3%BMY42 more
Drug Manufacturers - GeneralBiotechnologyMedical - DiagnosticsMedical - Healthcare PlansMedical - DevicesDrug Manufacturers - SpecialtyOther
J.P. Morgan JDOC · 54 holdings · tile size = share of the fund · as of Nov 6, 2026
All 39 Health Care ETFs
YTD| # | Trend | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDRReadDesk | 0.08% | 1.4% | +20.9% | +20.9% | $50.9B | |
| 2 | VHT | Health CareReadDesk | 0.09% | 1.4% | +19.7% | +19.7% | $19.1B | |
| 3 | XBI | State Street SPDR S&P BiotechReadDesk | 0.35% | 0.4% | +21.8% | +21.8% | $10.9B | |
| 4 | IYH | U.S. HealthcareReadDesk | 0.37% | 1.0% | +20.3% | +20.3% | $4.7B | |
| 5 | IXJ | Global HealthcareReadDesk | 0.38% | 1.2% | +19.7% | +19.7% | $4.6B | |
| 6 | IHI | U.S. Medical DevicesReadDesk | 0.37% | 0.4% | −2.7% | −2.7% | $4.1B | |
| 7 | FHLC | Fidelity MSCI Health CareReadDesk | 0.08% | 1.2% | +20.0% | +20.0% | $4.0B | |
| 8 | ARKG | ARK Genomic RevolutionReadDesk | 0.75% | — | +54.0% | +54.0% | $2.2B | |
| 9 | IHE | U.S. PharmaceuticalsReadDesk | 0.37% | 1.4% | +25.6% | +25.6% | $1.6B | |
| 10 | IHF | U.S. Healthcare ProvidersReadDesk | 0.37% | 0.9% | +24.9% | +24.9% | $1.5B | |
| 11 | PBPH | Portfolio Building Block World Pharma and BiotechReadDesk | 0.13% | 0.1% | +22.8% | +22.8% | $1.2B | |
| 12 | FXH | First Trust Health Care AlphaDEXReadDesk | 0.61% | 0.5% | +22.1% | +22.1% | $1.2B | |
| 13 | FTXH | First Trust Nasdaq PharmaceuticalsReadDesk | 0.60% | 0.7% | +31.5% | +31.5% | $1.2B | |
| 14 | PPH | VanEck PharmaceuticalReadDesk | 0.36% | 1.8% | +17.4% | +17.4% | $1.1B | |
| 15 | PJP | PharmaceuticalsReadDesk | 0.58% | 0.9% | +21.9% | +21.9% | $598M | |
| 16 | BBH | VanEck BiotechReadDesk | 0.35% | 0.4% | +32.6% | +32.6% | $519M |
1–16 of 39Page 1 of 3
Health Care · current AUM · as of Nov 6, 2026
JDOC Payouts by Year
3YLatest payout, Dec 2025
$0.51
a share · once a year
0.8% yield
0.8% yield
3 years added up
$3.41 a share
$3.41 a share
J.P. Morgan JDOC · per-share distributions by ex-date · 2023–2025
JDOC’s Peers
YTD| # | Trend | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDR ETFReadVersus | 0.08% | 1.4% | −2.5% | +20.9% | +29.6% | $50.9B | |
| 2 | VHT | Vanguard Health Care ETFReadVersus | 0.09% | 1.4% | −2.9% | +19.7% | +28.0% | $19.1B | |
| 3 | XBI | State Street SPDR S&P Biotech ETFReadVersus | 0.35% | 0.4% | −6.7% | +21.8% | +37.9% | $10.9B | |
| 4 | IYH | iShares U.S. Healthcare ETFReadVersus | 0.37% | 1.0% | −2.8% | +20.3% | +28.8% | $4.7B | |
| 5 | IXJ | iShares Global Healthcare ETFReadVersus | 0.38% | 1.2% | +3.2% | +19.7% | +28.6% | $4.6B | |
| 6 | JDOC | JPMorgan Healthcare Leaders ETFThis fund | 0.65% | 0.8% | −2.4% | +14.0% | +22.0% | $10.1M |
#21 of 33 this year · #32 cheapest of 39 · sorted by assetsOpen the Sectors table →
JDOC and its peer group · total return · as of Nov 6, 2026
Cards for This View
JDOC’s Top 10 Holdings
Today49.3%of JDOC sits in these 10
4NOVN.SNovartis Ag4.64%
J.P. Morgan JDOC · weight in the fund · as of Nov 6, 2026
JDOC’s Holdings
TodayLLYEli Lilly And Company8.6%ABBV8.3%UNH5.3%NOVN.SW4.6%JNJ4.6%TMO4.3%AZN.L4.2%MRK3.6%DHR2.8%ISRG2.8%SYK2.3%BMY2.1%COR2.1%IQV2.0%REGN2.0%4502.T1.9%ROP.SW1.8%HUM1.8%EW1.8%BIIBBAYN.VRTX32 more
LLYEli Lilly And Company8.6%ABBV8.3%UNH5.3%NOVN.SW4.6%JNJ4.6%TMO4.3%AZN.L4.2%MRK3.6%DHR2.8%ISRG2.8%SYK2.3%BMY42 more
Drug Manufacturers - GeneralBiotechnologyMedical - DiagnosticsMedical - Healthcare PlansMedical - DevicesDrug Manufacturers - SpecialtyOther
J.P. Morgan JDOC · 54 holdings · tile size = share of the fund · as of Nov 6, 2026
JDOC vs Peer Average
YTDJDOCAvsBPeer average
1D−2.4%−3.4%
1M+9.6%+4.6%
3M+6.8%+3.5%
YTD+14.0%+19.7%
1Y+22.0%+29.0%
3Y[…]+75.3%
5Y[…]+27.3%
3–2JDOC wins
38 Health care peers · each row scaled to its leader